Revenue
396 thousand USD
2026 Q2 · USD
Exact inputs and evidence
- Revenue: 395991 USD Source
Fundies. English
Carmell Corporation
EDGARAnnual consolidated revenue for 2025: about USD 1.913M, using the latest reported figures. The previous period, 2024, was about USD 50.32K.
Latest quarter
Operating margin
-182.87%
2026 Q2 · %
Operating cash flow
-224 thousand USD
2026 Q2 · USD
- Cash and cash equivalents
- 35.5 thousand USD Source
Exact value
35471 USD
- Long-term debt including current maturities
- 9.36 million USD Source
Exact value
9364274 USD
- Shares outstanding
- 2.48 million shares Source
Exact value
2475321 shares
Reported share-count change
66.83% · 992 thousand shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
1.69 million USD
2025-07-01 – 2026-06-30
Net income
-6.83 million USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
Operating cash flow
-2.45 million USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
- Operating cash flow: -3022899 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: -1589143 USD · 2025-01-01 – 2025-06-30 Source
- Operating cash flow: -3329266 USD · 2025-01-01 – 2025-12-31 Source
- Operating cash flow: -3022899 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: -485291 USD · 2026-01-01 – 2026-03-31 Source
- Operating cash flow: -709172 USD · 2026-01-01 – 2026-06-30 Source
- Operating cash flow: -485291 USD · 2026-01-01 – 2026-03-31 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-08-14.
Financial data available through: 2025-12-31.
Coverage by financial measure
- Revenue: 3 of 11 periods available· newest 2025-12-31
- Operating income: 5 of 11 periods available· newest 2025-12-31
- Net income: 5 of 11 periods available· newest 2025-12-31
- Operating cash flow: 5 of 11 periods available· newest 2025-12-31
- Capital expenditure: 4 of 11 periods available· newest 2025-12-31
- Total assets: 3 of 11 periods available· newest 2025-12-31
- Total liabilities: 3 of 11 periods available· newest 2025-12-31
- Current assets: 3 of 11 periods available· newest 2025-12-31
- Current liabilities: 3 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 3 of 11 periods available· newest 2025-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: 3 of 11 periods available· newest 2025-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
+3,701.4%Prior period
USD 50,318
–
Current period
USD 1.91 million
–
Exact inputs and evidence
1912811 − 50318 = 1862493 USD
50318 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source1912811 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 3.46 millionPrior period
−USD 10.37 million
–
Current period
−USD 6.91 million
–
Exact inputs and evidence
-6905282 − -10368261 = 3462979 USD
-10368261 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-6905282 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 563,990Prior period
−USD 3.89 million
–
Current period
−USD 3.33 million
–
Exact inputs and evidence
-3329266 − -3893256 = 563990 USD
-3893256 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-3329266 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2025 2025-01-01 – 2025-12-31
- Revenue USD 1.91 million 100% of revenue
- Cost of revenue USD 818,051 43% of revenue
- Operating expenses USD 8.2 million 429% of revenue
- Operating income −USD 7.11 million −372% of revenue
- Tax, interest and other Derived −USD 202,291 −11% of revenue
- Net income −USD 6.91 million −361% of revenue
Cash
- Operating cash flow −USD 3.33 million −174% of revenue
- Capital expenditure USD 14,225 0.7% of revenue
- Free cash flow Derived −USD 3.34 million −175% of revenue
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2023 Not shown: operating income or net income is not reported.
- 2024 Operating loss: operating costs were 10,034% of revenue.
- 2025 Operating loss: operating costs were 472% of revenue.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2023 2023-01-01 – 2023-12-31 | 0 | 5943556 Derived | -5943556 | 9501531 Derived | -15445087 | -8378678 Derived | Source
|
| 2024 2024-01-01 – 2024-12-31 | 50318 | 5048816 Derived | -4998498 | 5369763 Derived | -10368261 | Unavailable | Source
|
| 2025 2025-01-01 – 2025-12-31 | 1912811 | 9020384 Derived | -7107573 | -202291 Derived | -6905282 | -3343491 Derived | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 1.9M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Revenue | 0 |
|
| 2024 | Revenue | 50318 |
|
| 2025 | Revenue | 1912811 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
3,701.4% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Year over year | No prior comparable period |
|
| 2024 | Year over year | No prior comparable period |
|
| 2025 | Year over year | 3,701.4% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin -371.6% 2025
Net margin -361% 2025
Free cash flow margin -174.8% 2025
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Operating margin | Not reported |
|
| 2024 | Operating margin | -9,933.8% |
|
| 2025 | Operating margin | -371.6% |
|
| 2023 | Net margin | Not reported |
|
| 2024 | Net margin | -20,605.5% |
|
| 2025 | Net margin | -361% |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | -174.8% |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD -3.3M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Operating cash flow | -8348208 |
|
| 2024 | Operating cash flow | -3893256 |
|
| 2025 | Operating cash flow | -3329266 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
USD -3.3M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Free cash flow | -8378678 |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | -3343491 |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
347.9% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Liabilities / assets | 61.3% |
|
| 2024 | Liabilities / assets | 419.7% |
|
| 2025 | Liabilities / assets | 347.9% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
0.25× 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Current assets / current liabilities | 1.63× |
|
| 2024 | Current assets / current liabilities | 0.16× |
|
| 2025 | Current assets / current liabilities | 0.25× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2021 2021-01-01 – 2021-12-31 | −USD 6.48 million Exact valueExact value: -6478923 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.18 million Exact valueExact value: -1176829 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 7,273 Exact valueExact value: 7273 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.18 million Calculation and evidence-1176829 − 7273 USD Exact free cash flow: -1184102 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-21 – 2021-12-31 | −USD 329,382 Exact valueExact value: -329382 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 451,167 Exact valueExact value: -451167 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2022-01-01 – 2022-12-31 | −USD 9.05 million Exact valueExact value: -9051334 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.43 million Exact valueExact value: -3428707 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 7,164 Exact valueExact value: 7164 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.44 million Calculation and evidence-3428707 − 7164 USD Exact free cash flow: -3435871 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 15.45 million Exact valueExact value: -15445087 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 8.35 million Exact valueExact value: -8348208 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 30,470 Exact valueExact value: 30470 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 8.38 million Calculation and evidence-8348208 − 30470 USD Exact free cash flow: -8378678 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 10.37 million Exact valueExact value: -10368261 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.89 million Exact valueExact value: -3893256 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | −USD 6.91 million Exact valueExact value: -6905282 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.33 million Exact valueExact value: -3329266 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 14,225 Exact valueExact value: 14225 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.34 million Calculation and evidence-3329266 − 14225 USD Exact free cash flow: -3343491 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
33 filings · 1,255 latest values · 1,264 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001842939, 1842939, ALPA, CTCX, XAGE, edgar:1842939
Also known as ALPHA HEALTHCARE ACQUISITION CORP III, Alpha Healthcare Acquisition Corp. III, CARMELL CORPORATION, Carmell Corp, Carmell Corporation, LONGEVITY HEALTH HOLDINGS, INC., Longevity Health Holdings, Inc.